Home | Business News | Browse by Publication | P | Pharma Marketletter

Roche's Copegus/Pegasys "cost effective," study.

Publication: Pharma Marketletter
Publication Date: 29-MAY-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Swiss drug major Roche says that interim results from a study investigating the cost-effectiveness of treating US patients who have mild chronic hepatitis C using Pegasys (peginterferon alpha- 2a) plus Copegus (ribavirin) were positive.

The study, which was presented at the annual Digestive Disease Week conference in Los Angeles,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Senior appointments at Neurochem., May 29, 2006
Study shows atomoxetine's efficacy as ADHD treatment., May 29, 2006
Sequenom recruits Elizabeth Dragon to lead R&D., May 29, 2006
MedImmune hires Peter Greenlead as senior VP, marketing and sales., May 29, 2006
Biopure names Gerson Greenberg VP medical affairs., May 29, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.